FibroGen Inc
NASDAQ:FGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
Prosegur Compania de Seguridad SA
OTC:PGCSF
|
ES |
|
Japan Post Bank Co Ltd
OTC:JPSTF
|
JP |
|
Kinder Morgan Inc
NYSE:KMI
|
US |
|
V
|
VICI Properties Inc
XMUN:1KN
|
US |
|
N
|
Norfolk Southern Corp
DUS:NFS
|
US |
|
Tutor Perini Corp
NYSE:TPC
|
US |
|
G
|
Globalstar Inc
AMEX:GSAT
|
US |
|
EchoStar Corp
NASDAQ:ECHO
|
US |
|
S
|
Swire Pacific Ltd
OTC:SWRAY
|
HK |
|
P
|
Public Service Enterprise Group Inc
F:PSE
|
US |
|
Energy Recovery Inc
NASDAQ:ERII
|
US |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
L
|
Lumentum Holdings Inc
F:LU2
|
US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
Barratt Developments P L C
OTC:BTDPY
|
UK |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
|
D
|
Danone SA
XMUN:BSN
|
FR |
|
K
|
KDDI Corp
SWB:DIP
|
JP |
|
BlackRock TCP Capital Corp
NASDAQ:TCPC
|
US |
|
Summit Materials Inc
NYSE:SUM
|
US |
|
H
|
Halliburton Co
XHAM:HAL
|
US |
Bankruptcy Probability
FibroGen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
FibroGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
FibroGen Inc
NASDAQ:FGEN
|
32.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
232.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
FibroGen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, FibroGen Inc has total debt of 19.5m USD. This includes both short-term (0 USD) and long-term (19.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
